{"id":59230,"date":"2025-10-31T05:42:56","date_gmt":"2025-10-31T05:42:56","guid":{"rendered":"https:\/\/rechemco.to\/?post_type=product&#038;p=59230"},"modified":"2026-07-28T03:36:23","modified_gmt":"2026-07-28T03:36:23","slug":"piptapentadol-eu","status":"publish","type":"product","link":"https:\/\/rechemco.to\/ro\/piptapentadol-eu\/","title":{"rendered":"PiPTapentadol UE"},"content":{"rendered":"<p class=\"wp-block-paragraph\">\ud83e\uddea <strong>PiPTapentadol \u2013 Prezentare structural\u0103 \u0219i farmacologic\u0103<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Clasificare chimic\u0103<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PiPTapentadol<\/strong> este un <strong>analog opioid sintetic<\/strong> derivat structural din <strong>tapentadol<\/strong>, el \u00eensu\u0219i un analgezic cu ac\u021biune central\u0103 care combin\u0103 <strong>agonismul receptorilor \u03bc-opioizi<\/strong> cu <strong>inhibarea recapt\u0103rii norepinefrinei (NRI)<\/strong>.<br>\u00cen PiPTapentadol, <strong>amina primar\u0103<\/strong> gruparea tapentadolului este substituit\u0103 cu o <strong>fragment de tip piperidin\u0103 sau piperazin\u0103<\/strong>, modific\u00e2ndu-i afinitatea pentru receptor \u0219i propriet\u0103\u021bile farmacocinetice.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aceast\u0103 modificare plaseaz\u0103 PiPTapentadol \u00een cadrul mai larg al <strong>familiei de opioide arilmetilamin\u0103 \/ fenetilamin\u0103<\/strong>, al\u0103turi de al\u021bi analogi de sintez\u0103 investiga\u021bi \u00een <strong>cercetare \u00een toxicologie medico-legal\u0103 \u0219i cartografierea receptorilor<\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Caracteristici chimice<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Structura de baz\u0103<\/strong>: Derivat din <strong>(\u00b1)-3-(3-hidroxifenil)-N,N-dimetilmetilbutanamin\u0103<\/strong> (schelet de tapentadol)<\/li>\n\n\n\n<li><strong>Substitu\u021bie tipic\u0103<\/strong>: \u00cenlocuirea aminei primare cu <strong>piperidin\u0103 sau izopropilpiperidin\u0103 (PiP)<\/strong> grup<\/li>\n\n\n\n<li><strong>Grupe func\u021bionale<\/strong>: Hidroxil fenolic, amin\u0103 ter\u021biar\u0103, alcool secundar<\/li>\n\n\n\n<li><strong>Greutate molecular\u0103 prezis\u0103<\/strong>: ~275\u2013310 g\/mol (\u00een func\u021bie de forma de sare)<\/li>\n\n\n\n<li><strong>Forme probabile de sare<\/strong>Clorhidrat sau fumarat<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Farmacologie (Prev\u0103zut\u0103 din analogie structural\u0103)<\/strong><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Agonismul receptorului \u03bc-opioid (MOR):<\/strong><br>Gruparea hidroxil fenolic \u0219i gruparea amin\u0103 bazic\u0103 men\u021bin afinitatea MOR similar\u0103 cu tapentadolul, conferind <strong>propriet\u0103\u021bi analgezice \u0219i sedative<\/strong> \u00een testele de receptori.<\/li>\n\n\n\n<li><strong>Inhibarea recapt\u0103rii noradrenalinei (NRI):<\/strong><br>Lan\u021bul lateral aminic extins poate p\u0103stra activitatea NRI, suger\u00e2nd un <strong>mecanism dual<\/strong> combin\u00e2nd modula\u021bia opioid\u0103 \u0219i noradrenergic\u0103.<\/li>\n\n\n\n<li><strong>Afinitate redus\u0103 pentru recaptarea serotoninei:<\/strong><br>Comparativ cu analogii tramadolului, PiPTapentadol prezint\u0103 probabil un efect serotoninergic minim.<\/li>\n\n\n\n<li><strong>Efecte a\u0219teptate (observa\u021bie de cercetare):<\/strong>\n<ul class=\"wp-block-list\">\n<li>Analgezie central\u0103 (mediat\u0103 de MOR)<\/li>\n\n\n\n<li>Sedare, mioz\u0103, depresie respiratorie (dependent\u0103 de doz\u0103)<\/li>\n\n\n\n<li>Tonus noradrenergic crescut (proprietate u\u0219or stimulant\u0103 la doze mici)<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Considera\u021bii privind toxicologia \u0219i siguran\u021ba<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Nu sunt disponibile date farmacocinetice la om.<\/li>\n\n\n\n<li>Ca \u0219i \u00een cazul tuturor analogilor opioizi noi, PiPTapentadol prezint\u0103 <strong>risc ridicat de depresie respiratorie, depresie a SNC \u0219i dependen\u021b\u0103<\/strong>.<\/li>\n\n\n\n<li>Toleran\u021ba \u00eencruci\u0219at\u0103 cu alte opioide este probabil\u0103, dar imprevizibil\u0103.<\/li>\n\n\n\n<li>\u00cen cazurile medico-legale, analogii tapentadolului au fost implica\u021bi \u00een <strong>supradoze fatale<\/strong> atunci c\u00e2nd sunt utiliza\u021bi abuziv.<\/li>\n\n\n\n<li>Detec\u021bia analitic\u0103 poate necesita <strong>LC-MS\/MS<\/strong> cu tranzi\u021bii specifice ale ionilor precursoare unice pentru fragmentul substituit cu PiP.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Utilizare criminalistic\u0103 \u0219i analitic\u0103<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PiPTapentadol poate ap\u0103rea \u00een contextul:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Panouri de screening pentru opioide de designer<\/strong><\/li>\n\n\n\n<li><strong>Elaborarea standardelor de referin\u021b\u0103 toxicologice<\/strong><\/li>\n\n\n\n<li><strong>Modelarea rela\u021biei structur\u0103\u2013activitate (SAR)<\/strong> pentru analgezicele sintetice<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Contextul legal \u0219i etic<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tapentadolul este un <strong>opioid prescris controlat<\/strong> \u00een majoritatea jurisdic\u021biilor.<\/li>\n\n\n\n<li>Analogi s\u0103i (inclusiv PiPTapentadol) sunt <strong>neaproba\u021bi pentru uz medical<\/strong> \u0219i pot intra sub inciden\u021ba <strong>legile privind controlul analogilor sau al substan\u021belor psihoactive noi<\/strong>.<\/li>\n\n\n\n<li>Orice manipulare trebuie s\u0103 respecte <strong>reglement\u0103rile locale privind substan\u021bele controlate<\/strong> \u0219i s\u0103 fie limitat\u0103 la <strong>laboratoare analitice sau academice autorizate<\/strong>.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">\u26a0\ufe0f <strong>Summary<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PiPTapentadol<\/strong> este un <strong>analog opioid experimental derivat din tapentadol<\/strong> investigat pentru legarea sa unic\u0103 de receptori \u0219i profilul farmacologic. Combin\u0103 <strong>agonismul \u03bc-opioid<\/strong> cu poten\u021bial <strong>inhibarea recapt\u0103rii noradrenalinei<\/strong>, dar nu dispune de date toxicologice, de siguran\u021b\u0103 sau clinice formale. Utilizarea \u00een cercetare este strict limitat\u0103 la medii de laborator controlate, cu respectarea deplin\u0103 a reglement\u0103rilor aplicabile.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">De ce s\u0103 cump\u0103ra\u021bi&nbsp;<strong><strong>PiPTapentadol<\/strong><\/strong>&nbsp;de la RECHEMCO?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u2605 Avem o lung\u0103 istorie comercial\u0103 pe pia\u021b\u0103, astfel \u00eenc\u00e2t s\u0103 beneficia\u021bi de experien\u021ba noastr\u0103. <br>\u2605&nbsp;<strong><strong><strong>PiPTapentadol<\/strong><\/strong><\/strong>&nbsp;a fost testat\u0103 \u0219i verificat\u0103.<br>\u2605 Accept\u0103m diferite metode de plat\u0103, cum ar fi Bitcoin, Monero \u0219i s\u00e2rm\u0103 bancar\u0103.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Ce ve\u021bi primi atunci c\u00e2nd cump\u0103ra\u021bi&nbsp;<strong><strong>PiPTapentadol<\/strong><\/strong>&nbsp;de la RECHEMCO?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">- O pung\u0103 sigilat\u0103 din folie de aluminiu care con\u021bine cea mai bun\u0103 calitate&nbsp;<strong><strong><strong>PiPTapentadol<\/strong><\/strong><\/strong><br>\u2022 pulbere<br>- 99% Puritate<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<h2>PiPTapentadol \u2013 Analog al tapentadolului numai pentru cercetare<\/h2>\n<p><strong>PiPTapentadol<\/strong> este un analog structural al <em>tapentadol<\/em> prezent\u00e2nd o substitu\u021bie de tip piperidin\u0103 pe scheletul fenilpropilaminei.<br \/>\nEste investigat \u00een <strong>laboratoarele criminalistice \u0219i analitice<\/strong> ca parte a studiilor SAR \u0219i de toxicologie a opioidelor sintetice.<\/p>\n<ul>\n<li>Analog opioid cu ac\u021biune dual\u0103 (profil \u03bc-opioid \u0219i NRI)<\/li>\n<li>Pentru dezvoltarea metodelor LC\u2013MS\/MS \u0219i GC\u2013MS<\/li>\n<li>Strict pentru cercetare de laborator controlat\u0103<\/li>\n<\/ul>\n<p><em>Nu este destinat uzului uman sau veterinar. Manipula\u021bi \u00een conformitate cu standardele de siguran\u021b\u0103 institu\u021bionale \u0219i legale.<\/em><\/p>\n<p><strong>PiPTapentadol<\/strong> este expediat din Europa de dou\u0103 ori pe s\u0103pt\u0103m\u00e2n\u0103.<\/p>\n<p>Timp mediu de livrare: 10 zile lucr\u0103toare.<\/p>\n<p><strong>Toate drogurile artizanale v\u00e2ndute pe acest site sunt destinate cercet\u0103rii \u0219i aplica\u021biilor criminalistice.<\/strong><\/p>\n<p><b>ATEN\u021aIE!<br \/><\/b>\u00ceN CAZ DE PIERDERE, ADRES\u0102 GRE\u0218IT\u0102 SAU ORICE ALT\u0102 PROBLEM\u0102, PENTRU ACEST PRODUS NU SUNT PERMISE RE-EXPEDIERI SAU RAMBURS\u0102RI<\/p>\n<p>&nbsp;<\/p>","protected":false},"featured_media":59237,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[15],"product_tag":[1926,1933,1940,1929,1931,1937,1936,1473,1924,1938,1922,1925,1927,1932,1934,1939,1923,1930,1928,1935],"class_list":["post-59230","product","type-product","status-publish","has-post-thumbnail","product_cat-out-of-stock","product_tag-analytical-opioid-standard","product_tag-controlled-substance-analogue","product_tag-designer-opioid-analogue","product_tag-forensic-laboratory-compound","product_tag-forensic-toxicology-reference","product_tag-gc-ms-analytical-standard","product_tag-lc-ms-ms-reference-compound","product_tag-norepinephrine-reuptake-inhibitor","product_tag-opioid-metabolism-study","product_tag-opioid-receptor-pharmacology","product_tag-opioid-receptor-study","product_tag-opioid-sar-research","product_tag-opioid-toxicology-screening","product_tag-piptapentadol","product_tag-research-only-opioid-compound","product_tag-synthetic-analgesic-research","product_tag-synthetic-opioid-research","product_tag-tapentadol-analogue","product_tag-tapentadol-derivative","product_tag--opioid-agonist-analogue","first","instock","shipping-taxable","purchasable","product-type-variable"],"_links":{"self":[{"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/product\/59230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/comments?post=59230"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/media\/59237"}],"wp:attachment":[{"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/media?parent=59230"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/product_brand?post=59230"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/product_cat?post=59230"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/rechemco.to\/ro\/wp-json\/wp\/v2\/product_tag?post=59230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}